Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB13509ExperimentalSmall molecule
Aloxiprin: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Human Cyclooxygenases
- Formula / weight
- C9H8Al2O7 · 282.119 g/mol (avg)
Resolves to
Compound
Clinical / RWD
Structure
InChIKey
MXCPYJZDGPQDRA-UHFFFAOYSA-NSMILES[O--].[O--].[O--].[Al+3].[Al+3].CC(=O)OC1=CC=CC=C1C(O)=OWhat you can answer from here — as of June 15, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which companies are running trials of Aloxiprin, in which indications and phases, and which of those programs are still active?